NCT06238037Completed
Bone Mineral Density in Patients With Sarcoidosis
Source: ClinicalTrials.gov · Last updated 6 Mar 2025
Brief summary (registry, in English)
To assess the frequency and risk factors of decreased bone mineral density (BMD) and vertebral fractures in Danish patients with sarcoidosis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 144 (actual)
- First submitted
- 3 Jun 2022
- Start date
- 1 Dec 2019
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- University of Aarhus
- Diseases
- Osteoporosis
- NCT number
- NCT06238037
What you commit to
- Study type: Observational
- Participants enrolled: 144
- From 1 Dec 2019 to the primary completion date, 30 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability or unwillingness to adhere to the study
- Inability to give informed consent
Who the study is looking for
- Diagnosis of sarcoidosis
- Signed informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus University Hospital. Dep. of Respiatory Diseases and Allergology Coordinator of this site? Confirm its status | Aarhus N | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.